July 22, 2017 5:00 PM ET

Pharmaceuticals

Company Overview of GW Pharmaceuticals plc

Executive Profile

Volker Knappertz M.D., D.Sc.

Chief Medical Officer, GW Pharmaceuticals plc
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

----

Background

Dr. Volker Knappertz, MD, DSc., has been Chief Medical Officer of GW Pharmaceuticals plc since May 15, 2017. Dr. Knappertz serves as the Chief Medical Officer of Knopp Neurosciences Inc. Dr. Knappertz served as Vice President and Head of global cardiovascular drug development at Bayer Healthcare. Most recently, Dr. Knappertz served as the Vice President of clinical development for multiple sclerosis, oncology and biosimilar products at Teva Pharmaceuticals, he oversaw ...

Corporate Headquarters

Sovereign House
Cambridge, Cambridgeshire CB24 9BZ

United Kingdom

Phone: 44 1223 266 800
Fax: 44 1223 235 667

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Universität zu Köln

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth L. Waggoner Esq., J.D.Chairman, CEO, President, General Counsel & Secretary
PharmaCyte Biotech, Inc.
$195.0K
Saeed Motahari President, CEO & Director
INSYS Therapeutics, Inc.
--
Raymond C. Dabney Co-Founder, Chairman, Chief Executive Officer and President
Cannabis Science, Inc.
$225.0K
George E. Anastassov M.D., DDS, MBAChairman, Chief Executive Officer and President
AXIM Biotechnologies, Inc.
$240.0K
Stuart W. Titus Ph.D.Chief Executive Officer, President and Director
Medical Marijuana, Inc.
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GW Pharmaceuticals plc, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.